{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:42:28Z","timestamp":1789731748676,"version":"4.0.1"},"reference-count":0,"publisher":"BMJ","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["British Journal of Ophthalmology"],"published-print":{"date-parts":[[2004,8,1]]},"DOI":"10.1136\/bjo.2003.037044","type":"journal-article","created":{"date-parts":[[2004,7,17]],"date-time":"2004-07-17T02:02:42Z","timestamp":1090029762000},"page":"1069-1073","source":"Crossref","is-referenced-by-count":114,"title":["Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?"],"prefix":"10.1136","volume":"88","author":[{"given":"G L","family":"Chantada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo.2003.037044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T20:40:27Z","timestamp":1601066427000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo.2003.037044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,1]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8,1]]}},"URL":"https:\/\/doi.org\/10.1136\/bjo.2003.037044","relation":{},"ISSN":["0007-1161"],"issn-type":[{"value":"0007-1161","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8,1]]}}}